Plain-English translation of NCT07098663 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called to see if it's safe and how well it works in people with obesity, some of whom also have type 2 diabetes. Researchers want to understand how the medication works in your body, whether food affects how it's absorbed, and what side effects people might experience when taking it for several weeks.
Obesity and type 2 diabetes are major health challenges, and there is a need for new treatment options that can help people manage their weight and blood sugar more effectively. This trial will help determine whether this medication could be a useful addition to current treatment approaches.
You likely qualify if…
You likely don't qualify if…
Depending on which part of the study you join, you will take either the new medication or a placebo (a look-alike pill with no active ingredient) once or daily for up to 4 weeks. You'll visit a clinical research unit for dose administration and follow-up appointments, where staff will monitor your health, take blood samples, and watch for any side effects. A safety committee will be reviewing your information throughout the study to make sure participants remain safe.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Australia